Artelo Biosciences, Inc.
ARTL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 8/31/2021 | |
|---|---|---|---|---|
| Market Cap | $20 | $25 | $8 | $17 |
| - Cash | $2 | $3 | $7 | $7 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $18 | $22 | $1 | $10 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$10 | -$10 | -$10 | -$7 |
| % Margin | – | – | – | – |
| Net Income | -$10 | -$9 | -$10 | -$7 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.05 | -3.14 | -3.49 | -5.97 |
| % Growth | 2.9% | 10% | 41.5% | – |
| Operating Cash Flow | -$8 | -$8 | -$8 | -$6 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$8 | -$8 | -$8 | -$6 |